Study on the regulatory mechanism of acupuncture and moxibustion on autophagy mediated by chromatin remodeling in Crohn's disease

Shanghai Research Institute of Acupuncture and Meridian0 个研究点目标入组 60 人开始时间: 2017年2月21日最近更新: 2017年3月13日

适应症

试验速览

暂无简介。

•1. Diagnosis of Crohn's disease
•2. Aged 16-70
•3. Patients with mild or moderate CD (CDAI between 151 and 450)
•4. Not taking any medication or taking mesalazine, prednisone, immunosuppressive drugs
•5. Did not take or no longer taking biological agents such as infliximab
•6. Signed informed consent

•1. Pregnant or lactating patients
•2. Associations with heart, brain, liver, kidney and hematopoietic system of serious diseases
•3. Mental illness or other serious diseases
•4. Presence of skin disease, fistula, sinus, mutilation and other conditions in the acupoints selected in the study that can not be implemented moxibustion treatment
•5. Taking other medications that can lead to a CD symptom aggravating or changing the efficacy of drugs
•6. Associations with short bowel syndrome, symptoms of intestinal stenosis,
•7. Previous stomach or gastrointestinal tract surgery

发起方

Shanghai Research Institute of Acupuncture and Meridian